|
|
||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 23
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office
Appendix C
Meeting One Agenda14
Meeting One, March 3, 2008
Committee on Review of Priorities in the National Vaccine Plan
AGENDA
National Academy of Sciences Building
2101 Constitution Avenue NW, Washington, DC
Lecture Room
1:00 – 1:10 pm
Welcome and Committee Introductions
Claire V. Broome
Committee Chair
1:10 – 1:20 pm
Presentation
Anand Parekh
Acting Deputy Assistant Secretary for Health (Science and Medicine)
Office of the Assistant Secretary for Health
Department of Health and Human Services
14
A Website (http://www.iom.edu/vaccineplan) and listserv were created to provide information to the public about the committee’s work and to facilitate communication with the committee. Materials from the committee’s March 2008 meeting are available in electronic form on the website. Further, a list of materials reviewed by the committee (in the form in which they were reviewed) including all submissions of information from the public and many items not cited in this report, can be found in the study’s public access file, obtained from the National Academies Public Access Records Office at (202)334-3543 or http://www8.nationalacademies.org/cp/ManageRequest.aspx?key=48905.
OCR for page 24
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office
1:20 – 1:50 pm
Charge to the IOM Committee
CAPT Raymond A. Strikas
Medical Officer
U.S. Public Health Service
National Vaccine Program Office
Department of Health and Human Services
1:50 – 2:05 pm
Questions from the Committee
2:05 – 3:05 pm
Key Dimensions of the National Vaccine Plan: Since 1994 and Future
Melinda Wharton
Deputy Director
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
Norman Baylor
Director
Office of Vaccines Research and Review
Center for Biologics Evaluation
Food and Drug Administration
Carole A. Heilman
Director
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
3:05 – 3:20 pm
Questions from the Committee
3:20 – 3:30 pm
Break
3:30 – 4:10 pm
Key Dimensions of the National Vaccine Plan,
Jeffrey Kelman
Chief Medical Officer
Center for Beneficiary Choices
Centers for Medicare and Medicaid Services
Geoffrey Evans
Director
Division of Vaccine Injury Compensation
Healthcare Systems Bureau
Health Resources and Services Administration
Jerome Donlon
Chief Scientist Advisor & Medical Officer, Office of the
Assistant Secretary for Public Health Emergency
Preparedness
Department of Health and Human Services
4:10 – 4:30 pm
Questions from the Committee
OCR for page 25
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office
4:30 – 4:45 pm
Relationship Between the National Vaccine Plan and Healthy People 2020
RADM Penelope Slade Royall
Director
Office of Disease Prevention and Health Promotion
Office of Public Health and Science, Office of the Secretary
Department of Health and Human Service
4:45 – 5:15 pm
Status of the New National Vaccine Plan
Draft priorities for the National Vaccine Plan
Walter Orenstein
Professor of Medicine and Pediatrics
Emory University School of Medicine
Deputy Director, Emory Vaccine Center
Consultant to the National Vaccine Plan
Results of the first focus groups for public engagement
Richard Tardif
Oak Ridge Institute for Science and Education (ORISE)
Consultant to the National Vaccine Plan
Future plans for public engagement
Roger Bernier
Centers for Disease Control and Prevention
5:15 – 5:30 pm
Questions from the Committee
5:30 – 5:45 pm
Public Comments
5:45 pm
Adjourn